KATHLEEN BROWNING: Open Payments
NPI 1750617445 · ALEXANDRIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 60 payments from 19 companies in 2025. Trend: 2023 $1,198 · 2024 $1,141 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $302 |
| Axsome Therapeutics, Inc. | 8 | $158 |
| AstraZeneca Pharmaceuticals LP | 2 | $147 |
| Novo Nordisk Inc | 5 | $87 |
| Lilly USA, LLC | 5 | $87 |
| PFIZER INC. | 5 | $80 |
| Phathom Pharmaceuticals, Inc. | 1 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Amgen Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $48 |
Products named: VRAYLAR, Auvelity, BREZTRI, JARDIANCE, NURTEC ODT, VOQUEZNA, UBRELVY, Kerendia.
Industry payments across KY — which companies pay providers there.
